Find out what we're talking about
Posted on 09.23.21
A pair of antimalarial compounds finds new use for COVID-19: Artemisinin and Piperaquine
Repurposing existing compounds for COVID-19 research is an area of study that has exploded. Antiviral therapy, cell therapy, immunotherapy and herbal medicines have shown variable efficacy. A large number of clinical trials for potent...
Posted on 09.01.21
New use for old compound: Novobiocin used in fight against cancer
Researchers at Dana-Farber Cancer institute have discovered that the natural product Novibiocin, an antibiotic developed in the 1950s, can target and kill cancer cells that have abnormal BRCA genes, a gene involved with DNA repair. This...
Posted on 08.12.21
Technically Uncertain? Solutions for Antimicrobial Susceptibility Testing challenges
Recently, I attended the virtual, global ECCMID 2021 conference and was struck with the quality and sheer volume of information presented. After attending a jam-packed workshop entitled ‘AST Testing with EUCAST Methods and Breakpoints’ m...
Posted on 06.04.21
Hosted a digital booth at World Microbe Forum
We hosted a digital booth at the World Microbe Forum (WMF) this year. This meeting was a collaboration between ASM, FEMS, and several other scientific societies. It took place online June 24-24, 2021. Now more than ever, we have re...
Posted on 04.15.21
Antimicrobial Susceptibility Testing and Beyond: Optimized antimicrobials for AST
Pharmaceutical-grade antibiotics are designed for the human body, but are not optimized for in vitro systems. There are a number of ways to optimize your AST platforms to increase efficiency and performance. Many systems require the ant...